Biogen Idec has shortened its name to just Biogen and has introduced a new corporate identity and logo. Biogen Idec was created in 2003 through the merger of Biogen and IDEC Pharmaceuticals. The company has since focused R&D efforts in three core areas: neurology, immunology and hematology.   “Though we will no longer be known as Biogen Idec, we will continue to honor the contributions of IDEC to our growth, to patients and to society,” said George A. Scangos, Ph.D., chief executive officer ...